Return to Article Details
Cardiovascular and Renal Outcomes of Insulin-Sensitizing and Glucose-Lowering Agents in Type 2 Diabetes with Established Cardiovascular Disease: A Systematic Review and Meta-Analysis
Download
Download PDF